BCL9
Summary: BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008].
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:602597 Ensembl IDEnsembl:ENSG00000116128 HGNC IDHGNC:HGNC:1008 PHARMGKB IDPA25318 Map Location1q21.2 |
Gene Categories:
TRANSCRIPTION FACTOR COMPLEXGO terms in BCL9
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IEA | GO:0003713 | transcription coactivator activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0008013 | beta-catenin binding |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IDA | GO:0005801 | cis-Golgi network |
CC | IDA | GO:1990907 | beta-catenin-TCF complex |
Gene expression in normal tissue: BCL9
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in BCL9
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-195721 | Signaling by WNT |
reactome | R-HSA-201681 | TCF dependent signaling in response to WNT |
reactome | R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex |
reactome | R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex |
pid | betacatenin_nuc_pathway | Regulation of nuclear beta catenin signaling and target gene transcription |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in BCL9
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |